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What are the novel findings of this work?
In this prospective multicenter observational study of
late preterm singleton pregnancies at risk of fetal
growth restriction (FGR), fetal cerebral Doppler changes
were found to be associated with adverse perinatal
outcome.
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What are the clinical implications of this work?
We confirm an association between abnormal fetal cere-
bral Doppler and adverse perinatal outcome in late preterm
singleton pregnancies at risk of FGR. Whether cerebral
flow changes are a marker of fetal compromise and
whether intervention changes the risk for poor outcome
can be answered only in a randomized intervention study.
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ABSTRACT
Objectives To explore the association between fetal
umbilical and middle cerebral artery (MCA) Doppler
abnormalities and outcome in late preterm pregnancies at
risk of fetal growth restriction.
Methods This was a prospective cohort study of singleton
pregnancies at risk of fetal growth restriction at 32 + 0 to
36 + 6 weeks of gestation, enrolled in 33 European centers
between 2017 and 2018, in which umbilical and fetal
MCA Doppler velocimetry was performed. Pregnancies
were considered at risk of fetal growth restriction
if they had estimated fetal weight and/or abdominal
circumference (AC) < 10th percentile, abnormal arterial
Doppler and/or a fall in AC growth velocity of more than
40 percentile points from the 20-week scan. Composite
adverse outcome comprised both immediate adverse birth
outcome and major neonatal morbidity. Using a range of
cut-off values, the association of MCA pulsatility index
and umbilicocerebral ratio (UCR) with composite adverse
outcome was explored.
Results The study population comprised 856 women.
There were two (0.2%) intrauterine deaths. Median
gestational age at delivery was 38 (interquartile range
(IQR), 37–39) weeks and birth weight was 2478 (IQR,
2140–2790) g. Compared with infants with normal
outcome, those with composite adverse outcome (n = 93;
11%) were delivered at an earlier gestational age (36
vs 38 weeks) and had a lower birth weight (1900
vs 2540 g). The first Doppler observation of MCA
pulsatility index < 5th percentile and UCR Z-score above
gestational-age-specific thresholds (1.5 at 32–33 weeks
and 1.0 at 34–36 weeks) had the highest relative risks
(RR) for composite adverse outcome (RR 2.2 (95% CI,
1.5–3.2) and RR 2.0 (95% CI, 1.4–3.0), respectively).
After adjustment for confounders, the association between
UCR Z-score and composite adverse outcome remained
significant, although gestational age at delivery and
birth-weight Z-score had a stronger association.
Conclusion In this prospective multicenter study, signs
of cerebral blood flow redistribution were found to be
associated with adverse outcome in late preterm singleton
pregnancies at risk of fetal growth restriction. Whether
cerebral redistribution is a marker describing the severity
of fetal growth restriction or an independent risk factor
for adverse outcome remains unclear, and whether it is
useful for clinical management can be answered only in
a randomized trial. © 2020 The Authors. Ultrasound
in Obstetrics & Gynecology published by John Wiley
& Sons Ltd on behalf of the International Society of
Ultrasound in Obstetrics and Gynecology.
INTRODUCTION
Poor third-trimester fetal growth is associated with
adverse perinatal outcome1,2. The only therapeutic option
is timely delivery. This poses a dilemma as delivery too
early risks the baby suffering the effects of moderate–late
prematurity, whereas delivery too late risks further fetal
compromise increasing the risk of suboptimal outcome or
stillbirth. There remains little evidence on which to base
the timing of delivery of such babies in the late preterm
period. The problem is twofold: first, there is no consensus
on how to identify the fetus at risk for compromise and,
second, an evidence-based monitoring strategy remains to
be defined3.
The association between fetal middle cerebral (MCA)
and umbilical artery Doppler impedance ratios and
adverse outcome has been well described, deriving mainly
from retrospective studies 4–6. The key question is whether
abnormal cerebral artery Doppler is a non-injurious
response to fetal compromise or is itself a marker of
compromise and ongoing damage necessitating early
delivery. Without this information, it cannot be known if
using these Doppler parameters to decide on intervention
by delivery is beneficial for infant outcome. Guidelines of
the Royal College of Obstetricians and Gynaecologists
on small-for-gestational-age (SGA) fetuses7 state that
‘MCA Doppler may be a more useful test in SGA
fetuses detected after 32 weeks of gestation’, but perhaps
wisely do not define the parameters that should trigger
a decision to deliver. The usefulness of MCA Doppler
and cerebral blood flow redistribution in improving
perinatal and/or long-term outcome can be assessed only
by randomization in a prospective study, but current
data are insufficient to decide how such a trial should be
designed.
As part of the design process for the TRUFFLE-2 ran-
domized trial for determining optimal timing for delivery
in the context of late preterm fetal growth restriction, we
undertook a prospective observational feasibility study.
The objectives of this study were to quantify perinatal
morbidity and mortality in contemporary clinical prac-
tice and to determine which thresholds for umbilical and
MCA Doppler are most strongly associated with adverse
perinatal outcome in late preterm singleton pregnancies
at risk of fetal growth restriction, and which thus might
be most appropriate for evaluation in a future random-
ized interventional study in late preterm fetal growth
restriction.
METHODS
Setting
This was a prospective multicenter observational study
conducted between 1 April 2017 and 1 July 2018 in
33 European perinatal centers with fetal medicine and
specialized neonatal intensive care services.
Participants
Women were eligible if they had a singleton pregnancy
from 32 + 0 to 36 + 6 weeks of gestation with a fetus con-
sidered at risk for growth restriction, defined as estimated
fetal weight (EFW) and/or abdominal circumference (AC)
< 10th percentile, abnormal fetal arterial Doppler and/or
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 56: 173–181.
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a fall in AC growth velocity of more than 40 percentile
points from the 20-week scan. The references for EFW,
AC and Doppler parameters were based on local charts.
In order to be eligible, the fetus had to have positive
umbilical artery end-diastolic flow and a normal car-
diotocogram (CTG) with short-term variation of the fetal
heart rate > 3.0 ms, using Dawes–Redman CTG analysis.
Gestational age was calculated from certain menstrual
age and/or ultrasound assessment before 22 weeks of
gestation. Women were ineligible for inclusion if there
was known, planned or impending delivery based on
maternal obstetric complications, uterine contractions or
rupture of membranes, or if the fetus had a known or
suspected structural or chromosomal abnormality.
Further monitoring
Women were monitored using fetal biometry and Doppler
assessment of umbilical and fetal MCA pulsatility
index (PI), with a recommended minimum interval of
1 week between assessments. Z-scores were calculated
for MCA-PI and UCR using reference data from normal
pregnancies in the study of Arduini and Rizzo8, and
for fetal weight using the Hadlock fetal growth charts9.
UCR Z-scores were calculated as reported previously10.
The study was not blinded and clinicians who were
collecting the data were also involved directly in the
management and delivery of those women. However,
there was no guidance as to what findings should trigger
delivery, which was left to local custom. Management,
including maternal steroid administration and delivery,
was undertaken according to local clinical protocols.
Definitions
Maternal hypertension was defined as blood pressure
≥ 140/90 mmHg and proteinuria was defined as > 0.3 g/L
on a 24 h collection of urine or urine dipstick result
of ‘1+’ or more. Hypertensive disorders were defined
as chronic if hypertension existed prior to 20 weeks’
gestation or required treatment prior to pregnancy, or
as gestational if the onset of hypertension occurred after
20 weeks in the absence of proteinuria. Pre-eclampsia was
defined as hypertension and proteinuria, or hypertension
and clinical signs of pre-eclampsia11. HELLP syndrome
was defined as alanine aminotransferase > 70 IU/L with
platelets < 100 × 109/L and with evidence of hemolysis
from blood film or lactate dehydrogenase > 600 IU/L.
Outcomes
The primary outcome was a composite of abnormal con-
dition at birth or major neonatal morbidity. Abnormal
condition at birth was defined as at least one of the
following: Apgar score < 7 at 5 min, umbilical artery
pH < 7.0 or umbilical vein pH < 7.1, resuscitation with
intubation, chest compressions or medication, or still-
birth. Major neonatal morbidity until first discharge
home was defined as at least one of the following:
neurological abnormality (intracerebral hemorrhage
Grade 3 or 4, periventricular leukomalacia Grade 2
or 3, encephalopathy, or seizures necessitating anti-
epileptic drug treatment); cardiovascular abnormal-
ity (hypotensive treatment, ductus arteriosus treatment
or disseminated coagulopathy); respiratory morbidity
(respiratory support for more than 1 week, mechanical
ventilation, meconium aspiration or persistent pulmonary
hypertension); or sepsis (clinical sepsis with positive blood
culture, necrotizing enterocolitis (Bell’s stage 2 or greater)
or meningitis).
Data collection
Data were collected on a secure cloud-based electronic
data capture platform (Castor EDC, Amsterdam, The
Netherlands) curated by H.W. The database carried no
personal identifiers. Participants and their infants could
be identified only using unique study identifiers that were
stored in their recruiting center.
Analysis
Two analyses were undertaken. First, based on the last
fetal Doppler assessment within 1 week before delivery,
fetal Doppler parameters were compared between women
whose infant had composite adverse outcome and
those with normal outcome. Second, based on the
first abnormal fetal Doppler assessment after inclusion,
several fetal Doppler parameters and values were selected
as potential dichotomous predictors of the composite
primary outcome.
The selected dichotomous predictors were: absolute
MCA-PI < 5th percentile (equivalent to a Z-score of
−1.645) at any gestational age; gestational-age-specific
MCA-PI Z-score of <−2 at 32–33 weeks, <−1.5 at
34–35 weeks or <−1 at 36 weeks; absolute UCR value
≥ 95th percentile (Z-score, 1.645) at any gestational age;
UCR Z-score of ≥ 1.0 or ≥ 1.5 at any gestational age;
and three gestational-age-specific UCR Z-score ranges:
(1) ≥ 1.5 at 32–33 weeks or ≥ 1.0 at 34–36 weeks, (2)
≥ 1.5 at 32–33 weeks, ≥ 1.0 at 34–35 weeks or ≥ 0.5
at 36 weeks, and (3) ≥ 2.0 at 32–33 weeks, ≥ 1.5 at
34–35 weeks or ≥ 1.0 at 36 weeks.
The gestational-age-specific ranges were proposed
allowing a graduated range on the basis that clinical
decisions for delivery would require a more severely
abnormal Doppler at an early gestational age, and the
criteria for delivery would be more permissive closer to
term. For each cut-off, we compared the incidence of
composite adverse outcome between those women who
had an abnormal Doppler at least once and those who
never had an abnormal Doppler.
Statistical methods
Groups were compared with two-sided tests for statistical
significance using the Mann–Whitney U-test or Pearson’s
chi-square test, as appropriate. Relative risks for
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 56: 173–181.
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composite adverse outcome were calculated unadjusted.
In women who had the last Doppler measurement
obtained within 1 week before delivery, the association
of UCR with composite adverse outcome was adjusted
using logistic regression analysis for those parameters
that differed significantly between women with and
those without composite adverse outcome. Heterogeneity
between centers was tested using multilevel logistic
regression analysis. Data are presented as number (%) or
median (interquartile range (IQR)), as required. Statistical
calculations were performed using SPSS Statistics software
(version 25; IBM Corp., Armonk, NY, USA).
Ethical approval
This study was observational and practice (monitoring,
delivery, steroid administration) was based on existing
local guidance. Data were recorded anonymously after
delivery. In the UK, the Health Research Authority (HRA)
did not require the study to undergo ethical review, which
was the case in four further countries (14 centers). In six
countries (19 centers), ethical approval was required and
obtained, and participating women gave informed signed
consent.
RESULTS
Population
Complete delivery and outcome data were recorded for
873 patients with late preterm singleton pregnancy at
risk of fetal growth restriction in the study database.
Seventeen cases were excluded because of the presence of
major congenital abnormality, leaving 856 women and
their fetuses for the final cohort analysis. Demographic,
obstetric and fetal Doppler velocimetry characteristics of
the women included in the cohort are shown in Table 1.
Median gestational age and EFW at inclusion were 34
(IQR, 33–35) weeks and 1894 (IQR, 1624–2145) g,
respectively. Indication for inclusion was EFW and/or
AC < 10th percentile or a drop in AC growth velocity of
more than 40 percentiles in 842 (98%) fetuses, while in
98 (11%) an abnormal fetal arterial Doppler (umbilical
artery or MCA), according to local reference charts, was
observed.
Outcome
Median gestational age at delivery was 38 (IQR,
37–39; range, 32–42) weeks and birth weight was 2478
(IQR, 2140–2790; range, 1080–4255) g. The primary
composite adverse outcome occurred in 93 (11%) infants,
and its components are detailed in Table 2.
Abnormal condition at birth was present in 27 (3%)
fetuses. Among these, there were two (0.2%) antenatal
deaths, of which one was diagnosed at 33 + 3 weeks
(1 week after inclusion) and the second at 34 + 6 weeks
(2 weeks after inclusion). In both cases, umbilical artery
PI and UCR were < 95th percentile, while MCA-PI was
Table 1 Demographic, obstetric and Doppler variables in study
population of 856 late preterm singleton pregnancies at risk of fetal
growth restriction
Variable Value
Maternal age (years) 31 (28 to 35)
Nulliparous 524 (61)
BMI (kg/m2) 22.5 (20.3 to 26.0)
Smoker 68 (8)
Diabetes Type 1, 2 or gestational 70 (8)
Chronic hypertension 19 (2)
Other disease 246 (29)
At inclusion
Gestational age (weeks) 34 (33 to 35)
Inclusion indication*
EFW and/or AC < 10th percentile 792 (93)
AC growth velocity drop > 40
percentiles
50 (6)
Doppler abnormality 98 (11)
EFW (g) 1894 (1624 to 2145)
EFW Z-score −1.52 (−2.0 to −1.1)
Umbilical artery PI Z-score 0.1 (−0.3 to 0.6)
Umbilical artery PI ≥ 95th percentile 34 (4)
Middle cerebral artery PI Z-score −0.4 (−1.2 to 0.5)
Middle cerebral artery PI < 5th percentile 116 (14)
UCR Z-score 0.0 (−0.4 to 0.5)
UCR ≥ 95th percentile 35 (4)
Pre-eclampsia or HELLP 79 (9)
Any hypertensive disorder of pregnancy 119 (14)
Antihypertensive medication 103 (12)
Corticosteroids for fetal lung maturation
(> 24 h before delivery)
98 (11)
Total number of arterial Doppler
measurements
2751
Number of arterial Doppler measurements
per woman
4 (3 to 5)
Inclusion-to-delivery interval (days) 27 (14 to 37)
Delivery
Planned Cesarean section 219 (26)
Indication
Fetal condition (CTG or Doppler) 155/219 (71)
Fetal growth/EFW 25/219 (11)
Maternal condition 39/219 (18)
Induction of labor 369 (43)
Indication
Fetal condition (CTG or Doppler) 112/369 (30)
Fetal growth/EFW 213/369 (58)
Maternal condition 44/369 (12)
Spontaneous onset of labor 268 (31)
Cesarean section after onset of labor 117 (14)
Data are given as median (interquartile range), n (%), n or n/N (%).
*Multiple indications possible. AC, abdominal circumference; BMI,
body mass index; CTG, cardiotocogram; EFW, estimated fetal
weight; HELLP, hemolysis, elevated liver enzymes and low platelet
count; PI, pulsatility index; UCR, umbilicocerebral ratio.
< 5th percentile and birth weight Z-score was <−2.
There were no neonatal deaths before discharge. Major
neonatal morbidity occurred in 77 (9%) cases; the major
contributors were respiratory morbidity (53/77; 69%)
and infection (17/77; 22%).
Figure 1 shows the proportion of infants with abnormal
condition at birth and/or major neonatal morbidity before
discharge, according to gestational age at delivery and
birth weight Z-score. In comparison with infants with
normal outcome, composite adverse perinatal outcome
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 56: 173–181.
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Table 2 Perinatal outcome in study population of 856 late preterm
singleton pregnancies at risk of fetal growth restriction
Variable Value
Gestational age at delivery
(weeks)
38 (37–39) [32–42]
Birth weight (g) 2478 (2140–2790) [1080–4255]
Birth-weight Z-score −1.7 (−2.3 to −1.1) [−5.6 to 3.2]
Birth weight < 10th percentile 596 (70)
Male fetal sex 372 (43)
Composite adverse outcome* 93 (11)
Abnormal condition at birth† 27 (3)
Fetal death 2 (0)
Cord arterial pH < 7.0 or
venous pH < 7.1
7/712 (1)
5-min Apgar score < 7 15 (2)
Resuscitation with
intubation or medication
10 (1)
Major neonatal morbidity† 77 (9)
Cerebral 7 (1)
Cardiovascular 7 (1)
Respiratory 53 (6)‡
Infection 17 (2)
Abnormal condition at birth and
major neonatal morbidity
11 (1)
Neonatal death 0 (0)
Data are given as median (interquartile range) [range], n (%) or
n/N (%). *Composite adverse outcome defined as abnormal
condition at birth and/or major neonatal morbidity. †Multiple
conditions possible. ‡39/53 (74%) had only some respiratory
support for short duration in first week.
was associated strongly with lower gestational age at
delivery (36 (IQR, 34–38) vs 38 (IQR, 37–39) weeks)
and lower birth weight (1900 (IQR, 1557–2355) vs 2540
(IQR, 2220–2810) g). Infants with birth weight Z-score
<−2 had a significantly higher risk of composite adverse
outcome than did those with a higher birth weight Z-score
(RR, 2.7 (95% CI, 1.8–4.0); P < 0.01).
A Doppler evaluation was recorded within 1 week
before delivery in 584 (68%) women, of whom, 75
(13%) had composite adverse outcome and 509 (87%)
did not. Those with composite adverse outcome had
higher umbilical artery PI and lower MCA-PI at the
last assessment before delivery, were born at an earlier
gestational age and had lower birth weight (Table 3).
The Doppler velocimetry criteria were assessed by
comparing women who had an abnormal fetal Doppler
at least once at or after inclusion with women who
never had an abnormal fetal Doppler, according to the
different criteria (Table 4). Pregnancies with abnormal
Doppler were delivered earlier in gestation compared
with those in which the Doppler velocimetry results
remained in the normal range, regardless of the criterion
used (P < 0.05 for each comparison). Middle cerebral
artery PI < 5th percentile and four of the UCR Z-score
criteria were associated with an increased prevalence
of composite adverse outcome. The highest RR of
abnormal Doppler for composite adverse outcome was
for MCA-PI < 5th percentile (RR, 2.2 (95% CI, 1.5–3.2))
and high gestational-age-specific UCR Z-score (≥ 1.5
32–33
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Figure 1 Incidence of composite adverse outcome in 856 late
preterm singleton pregnancies at risk of fetal growth restriction,
according to gestational age at delivery (a) and birth-weight
Z-score (b). Composite adverse outcome defined as abnormal
condition at birth and/or major neonatal morbidity. Eleven infants
had both abnormal condition at birth and major neonatal
morbidity. , normal; , major neonatal morbidity; , abnormal
condition at birth + major neonatal morbidity; , abnormal
condition at birth.
at 32–33 weeks and ≥ 1.0 at 34–36 weeks) (RR, 2.0
(95% CI, 1.4–3.0)).
Compared with women with normal Doppler, those
who had an abnormal Doppler at any point after
inclusion, based on either the 5th percentile cut-off of
MCA-PI or the gestational-age-specific UCR Z-score
range, underwent prelabor Cesarean section more
frequently, had a lower gestational age at delivery and a
lower birth weight, and their infants had more frequently
composite adverse outcome (Table 5). Table 6 shows that
an abnormal Doppler occurred more frequently at an
earlier gestational age and that abnormal Doppler before
36 weeks was associated significantly with a higher rate
of composite adverse outcome.
Multilevel logistic regression analysis with an uncon-
ditional mean model using the participating centers and
composite adverse outcome showed a random inter-
cept variance of 0.21 (95% CI, 0.03–1.59; P = 0.06).
Calculated from this value, the intraclass correlation
coefficient was 0.06. This indicated that only 6% of the
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 56: 173–181.
on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
178 Stampalija et al.
chance of having an abnormal composite endpoint was
explained by differences between centers, and that further
assessment of confounders using logistic regression ana-
lysis without taking center into account was appropriate.
This analysis was performed in the subgroup of 584
women with the last Doppler measurement obtained
within 1 week before delivery, using UCR Z-score and
those variables that differed significantly between women
with and those without composite adverse outcome
(Table 3). The adjusted odds ratio for composite adverse
Table 3 Univariate analysis of demographic, obstetric and Doppler variables in 584 late preterm singleton pregnancies at risk of fetal
growth restriction that had last fetal Doppler measurement obtained within 1 week before delivery, according to presence or absence of
composite adverse outcome
Composite adverse outcome
Parameter
Present
(n = 75)
Not present
(n = 509)
Maternal age (years) 33 (29 to 37) 32 (28 to 35)*
Maternal age ≥ 35 years 30 (40) 138 (27)*
Nulliparous 49 (65) 311 (61)
Smoker 11 (15) 38 (7)
BMI (kg/m2) 21.8 (20.1 to 25.9) 22.3 (20.2 to 26.1)
Gestational hypertension or pre-eclampsia 24 (32) 78 (15)*
Umbilical artery PI Z-score 0.5 (−0.2 to 1.1) 0.1 (−0.3 to 0.6)*
Umbilical artery PI ≥ 95th percentile 9 (12) 31 (6)
Umbilical artery PI ≥ 90th percentile 13 (17) 53 (10)
Umbilical artery A/REDF 3 (4) 5 (1)
Middle cerebral artery PI Z-score −1.4 (−2.0 to −0.4) −1.0 (−1.6 to −0.3)*
Middle cerebral artery PI < 5th percentile 32 (43) 125 (25)*
UCR Z-score 0.6 (0.2 to 1.3) 0.4 (0.0 to 1.0)
UCR ≥ 95th percentile 9 (12) 65 (13)
UCR ≥ 90th percentile 18 (24) 95 (19)
Gestational age at delivery (weeks) 35 (34 to 37) 38 (37 to 39)*
Birth weight (g) 1820 (1520 to 2240) 2420 (2125 to 2725)*
Birth-weight Z-score −2.5 (−3.1 to −1.5) −1.8 (−2.3 to −1.2)*
Birth weight < 10th percentile 68 (91) 373 (73)*
Male sex 35 (47) 220 (43)
Data are given as median (interquartile range) or n (%). Composite adverse outcome defined as abnormal condition at birth and/or major
neonatal morbidity. *P < 0.05 by Mann–Whitney U-test or Fisher’s exact test. A/REDF, absent or reversed end-diastolic flow; BMI, body
mass index; PI, pulsatility index; UCR, umbilicocerebral ratio.
Table 4 Effect of different Doppler velocimetry criteria to define abnormal result in 856 late preterm singleton pregnancies: comparison of
participants who had abnormal Doppler observation at least once in study with those who never had abnormal Doppler
RR for composite
adverse outcome
Doppler always normal
Doppler abnormal at least once
Abnormal Doppler
criterion Pregnancies
First
abnormal
Doppler
to delivery
interval
(days)
Composite
adverse
outcome
GA at
delivery
(weeks) Pregnancies
Composite
adverse
outcome
GA at
delivery
(weeks) Value (95% CI) P
Middle cerebral artery PI
< 5th percentile 287 (34) 11 (4–20) 49/287 (17)* 38 (36–39)* 569 (66) 44/569 (8) 38 (37–39) 2.2 (1.5–3.2) < 0.01
Low GA-specific Z-score 329 (38) 12 (6–22) 43/329 (13) 37 (37–38)* 527 (62) 50/527 (9) 39 (37–40) 1.4 (0.9–2.0) 0.06
Umbilicocerebral ratio
≥ 90th percentile 168 (20) 7 (3–13) 25/168 (15) 37 (35–38)* 688 (80) 68/688 (10) 38 (37–39) 1.5 (1.0–2.3) 0.07
Z-score ≥ 1.0 223 (26) 8 (3–14) 34/223 (15)* 37 (36–38)* 633 (74) 59/633 (9) 38 (37–39) 1.6 (1.1–2.4) 0.02
Z-score ≥ 1.5 134 (16) 6 (2–11) 24/134 (18)* 37 (35–38)* 722 (84) 69/722 (10) 38 (37–39) 1.9 (1.2–2.9) < 0.01
High GA-specific Z-score 1 162 (19) 9 (3–14) 30/162 (19)* 37 (35–37)* 694 (81) 63/694 (9) 38 (37–39) 2.0 (1.4–3.0) < 0.01
High GA-specific Z-score 2 233 (27) 10 (5–16) 35/233 (15)* 37 (36–38)* 623 (73) 58/623 (9) 38 (37–40) 1.6 (1.1–2.4) 0.02
High GA-specific Z-score 3 126 (15) 7 (3–12) 19/126 (15) 37 (36–37)* 730 (85) 74/730 (10) 38 (37–39) 1.5 (0.9–2.4) 0.12
Data are given as n (%), median (interquartile range) or n/N (%), unless stated otherwise. Composite adverse outcome defined as abnormal
condition at birth and/or major neonatal morbidity. Low GA-specific Z-score: <−2 at 32–33 weeks, <−1.5 at 34–35 weeks, <−1 at
36 weeks; high GA-specific Z-score 1: ≥ 1.5 at 32–33 weeks, ≥ 1.0 at 34–36 weeks; high GA-specific Z-score 2: ≥ 1.5 at 32–33 weeks, ≥ 1.0
at 34–35 weeks, ≥ 0.5 at 36 weeks; high GA-specific Z-score 3: ≥ 2.0 at 32–33 weeks, ≥ 1.5 at 34–35 weeks, ≥ 1.0 at 36 weeks. *P < 0.05
by Mann-Whitney U-test or Fisher’s exact test, compared with pregnancies with Doppler assessment always normal. GA, gestational age;
PI, pulsatility index; RR, relative risk.
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Table 5 Gestational age (GA) at delivery, birth weight and perinatal outcome in 856 singleton pregnancies at risk of late preterm fetal
growth restriction, according to whether Doppler assessment was abnormal
Middle cerebral artery pulsatility index GA-specific UCR Z-score*
Variable
< 5th percentile
at least once
(n = 287)
Always normal
(n = 569)
High at
least once
(n = 162)
Always normal
(n = 694)
Inclusion-to-delivery interval (days) 25 (11–35)‡ 28 (16–39) 17 (7–28)‡ 29 (17–39)
First abnormal Doppler to delivery
interval (days)
11 (4–21) — 9 (3–14) —
CS before labor 87 (30)‡ 132 (23) 75 (46)‡ 144 (21)
Induction of labor 146 (51)‡ 223 (39) 68 (42) 301 (43)
Spontaneous onset of labor 54 (19)‡ 214 (38) 19 (12)‡ 249 (36)
CS during labor 44 (15) 73 (13) 27 (17) 90 (13)
Vaginal delivery 156 (54) 364 (64) 60 (37)‡ 460 (66)
GA at delivery (weeks) 38 (36–39)‡ 38 (37–39) 37 (35–37)‡ 38 (37–39)
Birth weight (g) 2380 (2000–2655)‡ 2555 (2213–2850) 2045 (1800–2391)‡ 2577 (2260–2830)
Birth weight < 10th percentile 219 (76)‡ 377 (66) 132 (81)‡ 464 (67)
Composite adverse outcome† 49 (17)‡ 44 (8) 30 (19)‡ 63 (9)
Abnormal condition at birth only 10 (3)§ 6 (1) 3 (2)¶ 13 (2)¶
Major neonatal morbidity only 38 (13)‡ 28 (5) 26 (16)‡ 40 (6)
Abnormal condition at birth and
major neonatal morbidity
1 (0) 10 (2) 1 (1) 10 (1)
*GA-specific UCR Z-score cut-offs: ≥ 1.5 at 32–33 weeks and ≥ 1.0 at 34–36 weeks. †Composite adverse outcome defined as abnormal
condition at birth and/or major neonatal morbidity. ‡P < 0.05 by Mann–Whitney U-test or Fisher’s exact test, compared with pregnancies
with Doppler assessment always normal. §Two cases of fetal death. ¶One case of fetal death. CS, Cesarean section; UCR, umbilicocerebral
ratio.
Table 6 Composite adverse outcome and gestational age (GA) at delivery in 856 singleton pregnancies at risk of late preterm fetal growth
restriction, according to whether Doppler assessment was abnormal and GA at assessment
Doppler abnormal at least once Doppler always normal RR for composite
adverse outcome
Abnormal Doppler
criterion/GA at assessment
Composite adverse
outcome
GA at delivery
(weeks)
Composite adverse
outcome
GA at delivery
(weeks) Value (95% CI) P
MCA-PI < 5th percentile
32–33 weeks 24/63 (38)† 36 (34–38)† 26/282 (9) 38 (37–39) 4.1 (2.6–6.7) < 0.01
34–35 weeks 14/94 (15)† 37 (36–38)† 37/508 (7) 38 (37–40) 2.0 (1.2–3.6) 0.02
36 weeks 6/63 (10) 38 (37–38)† 27/562 (5) 39 (38–40) 2.0 (0.9–4.6) 0.1
High GA-specific UCR Z-score*
32–33 weeks 12/31 (39)† 34 (33–36)† 34/316 (11) 38 (37–39) 4.1 (2.2–7.9) < 0.01
34–35 weeks 15/86 (17)† 36 (35–37)† 46/558 (8) 39 (37–40) 2.1 (1.2–3.7) 0.02
36 weeks 3/45 (7) 37 (37–38)† 34/620 (5) 39 (38–40) 1.2 (0.4–3.8) 0.7
Data are given as n/N (%) or median (interquartile range), unless stated otherwise. Women who had abnormal Doppler ultrasound were
counted only once at gestational age epoch in which first abnormal Doppler was registered. Women with normal Doppler could have
ultrasound at more than one gestational age epoch after inclusion; totals are therefore higher than total number of included women.
Composite adverse outcome defined as abnormal condition at birth and/or major neonatal morbidity. *GA-specific UCR Z-score cut-offs:
≥ 1.5 at 32–33 weeks and ≥ 1.0 at 34–36 weeks. †P < 0.05 by chi-square test or Mann–Whitney U-test, compared with pregnancies with
Doppler assessment always normal. MCA, fetal middle cerebral artery; PI, pulsatility index; RR, relative risk; UCR, umbilicocerebral ratio.
outcome of UCR Z-score was 1.3 per SD of UCR
(95% CI, 1.0–1.8; P = 0.04) (Figure 2). This model had
sensitivity of 79% at specificity of 75%. Gestational age
and birth weight Z-score had the greatest proportional
contribution to the model (0.45 and 0.29, respectively),
while that of UCR Z-score was 0.12, calculated using
multilayer perceptron analysis. In a similar analysis with
MCA-PI Z-score, it was observed that, after adjustment,
this parameter was not associated significantly with the
composite adverse endpoint.
DISCUSSION
In this study, we have shown that, in late preterm singleton
pregnancies at risk of fetal growth restriction, fetal
cerebral blood flow redistribution detected on Doppler
ultrasound within 1 week prior to delivery and the first
abnormal Doppler result at any time after inclusion
were both associated with composite adverse outcome.
The strength of our study is that a wide range of
centers were involved, which resulted in rapid prospective
recruitment of a large cohort of babies at risk of growth
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 56: 173–181.
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Figure 2 Adjusted odds ratios with 95% CI for composite adverse
outcome in 584 late preterm singleton pregnancies at risk of fetal
growth restriction and with Doppler measurement obtained within
1 week before delivery, calculated by logistic regression analysis,
using parameters that were statistically significant on univariate
analysis (Table 3). Missing variables from Table 3 were ejected from
analysis when P > 0.1. Model had sensitivity of 79% at specificity
of 75%, and area under receiver-operating-characteristics curve of
0.84 (95% CI, 0.79–0.89). Composite adverse outcome defined as
abnormal condition at birth and/or major neonatal morbidity.
BW, birth weight; GA, gestational age at delivery; MA, maternal
age; UCR, umbilicocerebral ratio.
restriction. The data provide a snapshot of the natural
history of late preterm growth restriction in relation to
fetal cerebral redistribution in contemporary practice. We
have also defined the prevalence of composite adverse
perinatal outcome in these fetuses and infants, according
to prespecified outcomes. The main weakness, as with
any observational study, is that the Doppler results
were revealed to the clinicians, thus making the results
susceptible to the treatment paradox.
With the above proviso, which also affects all
previous similar series, our results largely confirm the
association between fetal cerebral blood flow redistri-
bution and short-term adverse outcome in fetal growth
restriction4–6,12,13. Our findings are also consistent
with those of recent meta-analyses4,5, in which the
accuracy of fetal Doppler for the prediction of composite
adverse outcome was low, with sensitivity of 45–70%
and specificity of 75–95%, depending on the Doppler
parameter and thresholds used.
There was a significant association between these
predefined markers of abnormal Doppler velocimetry
and gestational age at delivery and the frequency of our
composite primary outcome (Tables 3, 5 and 6). Gesta-
tional age at delivery and birth weight Z-score should
be interpreted in this cohort as a proxy measure of the
severity of fetal growth restriction (Figures 1 and 2). We
might hypothesize that the most severe cases will reach
the limits of the uteroplacental supply earlier, which may
ultimately result in fetal asphyxia or death and increase
the risk of neonatal morbidity. The higher incidence of
the first finding of an abnormal Doppler parameter at an
earlier gestational age epoch, which was associated with
more preterm deliveries and a higher rate of composite
adverse outcomes, supports this (Table 6). Adjustment for
gestational age at delivery, birth weight, maternal age and
pre-eclampsia reduced the importance of the association
of UCR Z-score with the composite adverse endpoint,
but it remained statistically significant (Figure 2).
These data cannot be used to ascertain when delivery
should occur in the context of abnormal Doppler
and CTG findings. This can be evaluated only in a
well-conducted randomized trial before fetal MCA
Doppler can be recommended for this purpose. Hence,
these results have important implications for research,
in particular for the design of such a trial. The
parameters that dichotomized most effectively between
normal outcome and composite adverse perinatal
outcome were MCA-PI < 5th percentile or a graduated
gestational-age-specific range of UCR Z-score (≥ 1.5
at 32–33 weeks, ≥ 1.0 at 34–36 weeks). The rationale
behind choosing gestational-age-specific ranges reflects
the higher level of concern about fetal condition that
is required to trigger delivery at an earlier gestational
age compared with near term at a stage at which
neonatal morbidity and mortality are normally very
low, extrapolating from population studies14. However,
long-term morbidity from late preterm birth is not
negligible15,16. The extent to which this excess morbidity
is caused by late fetal growth restriction is unknown.
Furthermore, a ratio between the PI of the umbilical
and middle cerebral arteries may have a closer association
with perinatal outcome than does each parameter alone4,5.
Most studies on cerebral blood flow redistribution have
reported on the cerebroplacental ratio (CPR), which is
the inverse of UCR. We have used UCR as we believe
this ratio allows for better differentiation in the abnormal
range than does CPR10. A brief justification for this is that,
as fetal Doppler changes become more abnormal with
lower cerebral and higher umbilical artery impedance,
CPR tends towards an asymptote approximating to zero,
while UCR tends towards infinity, thus accentuating the
differences between abnormal values. Furthermore, most
commonly used ratios in medicine become larger with
increasing abnormality, similar to UCR.
In conclusion, a randomized trial is required to answer
the uncertainties in relation to triggering delivery based
on different parameters in late-preterm fetuses with, or
those at risk of, growth restriction. These data will help
in the selection of the potentially most effective diagnostic
method and its cut-off value to guide the design of such
a trial.
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